New Risk • Aug 03
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.6% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Board Change • May 20
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • May 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 24
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Sep 15
XRF Scientific Limited, Annual General Meeting, Oct 20, 2025 XRF Scientific Limited, Annual General Meeting, Oct 20, 2025. Location: at the quest hotel, 1 sunray drive, innaloo wa 6018, Australia Announcement • Aug 20
XRF Scientific Limited announces Annual dividend, payable on September 26, 2025 XRF Scientific Limited announced Annual dividend of AUD 0.0450 per share payable on September 26, 2025, ex-date on September 11, 2025 and record date on September 12, 2025. Reported Earnings • Aug 19
Full year 2025 earnings released: EPS: AU$0.074 (vs AU$0.064 in FY 2024) Full year 2025 results: EPS: AU$0.074 (up from AU$0.064 in FY 2024). Revenue: AU$59.4m (down 1.1% from FY 2024). Net income: AU$10.4m (up 17% from FY 2024). Profit margin: 18% (up from 15% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 13% decline forecast for the Machinery industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Aug 18
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Feb 04
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 24
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Nov 22
XRF Scientific Limited (ASX:XRF) agreed to acquire Labfit Pty Ltd for AUD 1.5 million. XRF Scientific Limited (ASX:XRF) entered into a Share Purchase Agreement to acquire Labfit Pty Ltd for AUD 1.5 million on November 22, 2024. A cash consideration of AUD 0.99 million will be paid by XRF Scientific Limited. The consideration consists of common equity of XRF Scientific Limited having a value of AUD 0.17 million to be issued for common equity of Labfit Pty Ltd. XRF Scientific Limited will pay an earnout/contingent payment of AUD 0.3 million cash. As part of consideration, AUD 1.46 million is paid towards common equity of Labfit Pty Ltd.
The transaction is subject to consummation of due diligence investigation and third party approval needed. Buy Or Sell Opportunity • Nov 12
Now 20% undervalued Over the last 90 days, the stock has risen 22% to AU$1.72. The fair value is estimated to be AU$2.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 8.8% per annum. Earnings are also forecast to grow by 12% per annum over the same time period. Announcement • Sep 16
XRF Scientific Limited, Annual General Meeting, Oct 21, 2024 XRF Scientific Limited, Annual General Meeting, Oct 21, 2024. Location: at the quest hotel, 1 sunray drive, innaloo wa 6018, Australia New Risk • Sep 09
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Upcoming Dividend • Sep 05
Upcoming dividend of AU$0.039 per share Eligible shareholders must have bought the stock before 12 September 2024. Payment date: 27 September 2024. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Australian dividend payers (6.2%). In line with average of industry peers (2.8%). Announcement • Aug 22
XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024 XRF Scientific Limited announced ordinary fully franked dividend of AUD 0.03900000 per share for the twelve months ended June 30, 2024. Record Date of September 13, 2024, Ex Date of September 12, 2024 and Payment Date of September 27, 2024. Reported Earnings • Aug 21
Full year 2024 earnings released: EPS: AU$0.064 (vs AU$0.056 in FY 2023) Full year 2024 results: EPS: AU$0.064 (up from AU$0.056 in FY 2023). Revenue: AU$60.1m (up 8.8% from FY 2023). Net income: AU$8.89m (up 16% from FY 2023). Profit margin: 15% (in line with FY 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 53% growth forecast for the Machinery industry in Australia. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth. Buy Or Sell Opportunity • Jul 29
Now 20% undervalued Over the last 90 days, the stock has risen 4.8% to AU$1.53. The fair value is estimated to be AU$1.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 17% in 2 years. Earnings are forecast to grow by 25% in the next 2 years. Announcement • Jul 26
XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million. XRF Scientific Limited (ASX:XRF) agreed to acquire remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.9 million on July 9, 2024. The consideration consists of cash and common equity of XRF Scientific Limited to be issued for common equity of Orbis Mining Pty. Ltd. Upon completion, XRF Scientific Limited will own 100% stake in Orbis Mining Pty. Ltd. The cash consideration will be funded from XRF's cash reserves. An earn-out will be payable, equivalent to 50% of the profits after tax for the 2025 financial year. Up to 50% of the earn-out can be paid in XRF shares. The cash and/or shares should be paid by October 31, 2025.
For the period ending June 30, 2024, Orbis Mining Pty. Ltd. reported total revenue of AUD 5.8 million. The expected completion of the transaction is July 31, 2024. Settlement of the Call Option shares is conditional on the satisfaction or waiver by December 31, 2024 of various conditions precedent, which include the XRF Scientific obtaining third-party approvals.
XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million on July 26, 2024. The consideration consists of AUD 1.96 million in cash and AUD 1.96 million through 1,332,604 shares. Announcement • Jul 09
XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024 XRF Scientific Limited announced that they will report fiscal year 2024 results on Aug 20, 2024 Buy Or Sell Opportunity • Jul 01
Now 23% undervalued Over the last 90 days, the stock has risen 12% to AU$1.35. The fair value is estimated to be AU$1.75, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 23% in the next 2 years. Buy Or Sell Opportunity • Jun 26
Now 22% undervalued Over the last 90 days, the stock has risen 7.3% to AU$1.32. The fair value is estimated to be AU$1.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 23% in the next 2 years. Buy Or Sell Opportunity • Jun 06
Now 20% undervalued Over the last 90 days, the stock has risen 10.0% to AU$1.32. The fair value is estimated to be AU$1.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 23% in the next 2 years. Buy Or Sell Opportunity • May 10
Now 21% undervalued Over the last 90 days, the stock has risen 17% to AU$1.28. The fair value is estimated to be AU$1.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 26% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 23% in the next 2 years. Reported Earnings • Feb 22
First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023) First half 2024 results: EPS: AU$0.033 (up from AU$0.028 in 1H 2023). Revenue: AU$28.6m (up 5.7% from 1H 2023). Net income: AU$4.48m (up 20% from 1H 2023). Profit margin: 16% (up from 14% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 54% growth forecast for the Machinery industry in Australia. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Jan 17
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$151.8m (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (AU$151.8m market cap, or US$99.6m). Announcement • Sep 22
XRF Scientific Limited, Annual General Meeting, Oct 31, 2023 XRF Scientific Limited, Annual General Meeting, Oct 31, 2023, at 11:00 W. Australia Standard Time. Location: The Quest Hotel, 1 Sunray Drive Innaloo Western Australia Australia Agenda: To consider and approve of remuneration report; to consider and election of Directors; and to consider and approve of issue of performance rights to Mr. Vance Stazzonelli or his nominee. Upcoming Dividend • Sep 21
Upcoming dividend of AU$0.033 per share at 3.0% yield Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Australian dividend payers (7.1%). In line with average of industry peers (2.8%). New Risk • Aug 23
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 3.0% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (AU$148.7m market cap, or US$95.5m). Reported Earnings • Aug 22
Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.045 in FY 2022) Full year 2023 results: EPS: AU$0.056 (up from AU$0.045 in FY 2022). Revenue: AU$55.3m (up 38% from FY 2022). Net income: AU$7.69m (up 26% from FY 2022). Profit margin: 14% (down from 15% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.8% p.a. on average during the next 2 years, compared to a 18% decline forecast for the Machinery industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 21
XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023 XRF Scientific Limited announced Ordinary Fully Paid dividend of AUD 0.03300000 for the twelve months ended June 30, 2023. Record Date of September 29, 2023, Ex Date of September 28, 2023 and Payment Date of October 13, 2023. Buying Opportunity • Aug 15
Now 24% undervalued Over the last 90 days, the stock is up 1.7%. The fair value is estimated to be AU$1.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 30%. Revenue is forecast to grow by 36% in 2 years. Earnings is forecast to grow by 30% in the next 2 years. Recent Insider Transactions • Jun 29
Non-Executive Director recently bought AU$89k worth of stock On the 27th of June, David Brown bought around 82k shares on-market at roughly AU$1.09 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$204k more in shares than they have sold in the last 12 months. New Risk • Jun 27
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$147.3m (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • May 22
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to AU$1.32, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 17x in the Machinery industry in Australia. Total returns to shareholders of 637% over the past three years. Recent Insider Transactions • May 10
Non-Executive Director recently bought AU$61k worth of stock On the 9th of May, David Brown bought around 51k shares on-market at roughly AU$1.19 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$126k more in shares than they have sold in the last 12 months. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to AU$1.18, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 17x in the Machinery industry in Australia. Total returns to shareholders of 543% over the past three years. Buying Opportunity • Mar 14
Now 21% undervalued Over the last 90 days, the stock is up 18%. The fair value is estimated to be AU$1.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 30%. Revenue is forecast to grow by 36% in 2 years. Earnings is forecast to grow by 30% in the next 2 years. Buying Opportunity • Feb 27
Now 23% undervalued Over the last 90 days, the stock is up 23%. The fair value is estimated to be AU$1.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 30%. Revenue is forecast to grow by 36% in 2 years. Earnings is forecast to grow by 30% in the next 2 years. Reported Earnings • Feb 22
First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022) First half 2023 results: EPS: AU$0.028 (up from AU$0.021 in 1H 2022). Revenue: AU$27.1m (up 46% from 1H 2022). Net income: AU$3.74m (up 34% from 1H 2022). Profit margin: 14% (down from 15% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Machinery industry in Australia. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Buying Opportunity • Nov 02
Now 21% undervalued Over the last 90 days, the stock is up 28%. The fair value is estimated to be AU$0.97, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10.0% over the last 3 years. Earnings per share has grown by 34%. Revenue is forecast to grow by 29% in 2 years. Earnings is forecast to grow by 18% in the next 2 years. Upcoming Dividend • Sep 22
Upcoming dividend of AU$0.025 per share Eligible shareholders must have bought the stock before 29 September 2022. Payment date: 14 October 2022. Payout ratio is a comfortable 56% and the cash payout ratio is 81%. Trailing yield: 3.6%. Lower than top quartile of Australian dividend payers (6.8%). Higher than average of industry peers (3.0%). Reported Earnings • Aug 24
Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021) Full year 2022 results: EPS: AU$0.045 (up from AU$0.038 in FY 2021). Revenue: AU$40.0m (up 28% from FY 2021). Net income: AU$6.08m (up 19% from FY 2021). Profit margin: 15% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 1.5% compared to a 176% growth forecast for the Machinery industry in Australia. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • May 31
Now 20% undervalued Over the last 90 days, the stock is up 18%. The fair value is estimated to be AU$0.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Earnings per share has grown by 40%. Revenue is forecast to grow by 16% in 2 years. Earnings is forecast to grow by 16% in the next 2 years. Buying Opportunity • May 13
Now 24% undervalued Over the last 90 days, the stock is up 19%. The fair value is estimated to be AU$0.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Earnings per share has grown by 40%. Revenue is forecast to grow by 16% in 2 years. Earnings is forecast to grow by 16% in the next 2 years. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. MD, Company Secretary & Director Vance Stazzonelli was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 24
First half 2022 earnings: EPS in line with expectations, revenues disappoint First half 2022 results: EPS: AU$0.021 (up from AU$0.018 in 1H 2021). Revenue: AU$18.5m (up 24% from 1H 2021). Net income: AU$2.79m (up 17% from 1H 2021). Profit margin: 15% (in line with 1H 2021). Revenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to stay flat compared to a 63% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Non-Executive Chairman Fred Grimwade was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Sep 23
Upcoming dividend of AU$0.02 per share Eligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 3.1%. Lower than top quartile of Australian dividend payers (5.4%). In line with average of industry peers (2.9%). Reported Earnings • Aug 26
Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$31.3m (up 7.6% from FY 2020). Net income: AU$5.13m (up 64% from FY 2020). Profit margin: 16% (up from 11% in FY 2020). Over the last 3 years on average, earnings per share has increased by 45% per year whereas the company’s share price has increased by 47% per year. Recent Insider Transactions • May 25
Non-Executive Director recently bought AU$72k worth of stock On the 21st of May, David Brown bought around 200k shares on-market at roughly AU$0.36 per share. In the last 3 months, they made an even bigger purchase worth AU$90k. Insiders have collectively bought AU$226k more in shares than they have sold in the last 12 months. Is New 90 Day High Low • Feb 27
New 90-day low: AU$0.28 The company is down 10.0% from its price of AU$0.32 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.24 per share. Recent Insider Transactions • Feb 27
Non-Executive Director recently bought AU$93k worth of stock On the 26th of February, David Brown bought around 300k shares on-market at roughly AU$0.31 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$103k more in shares than they have sold in the last 12 months. Reported Earnings • Feb 24
First half 2021 earnings released: EPS AU$0.018 (vs AU$0.012 in 1H 2020) The company reported a decent first half result with improved earnings and profit margins, although revenues were weaker. First half 2021 results: Revenue: AU$15.0m (down 5.0% from 1H 2020). Net income: AU$2.38m (up 47% from 1H 2020). Profit margin: 16% (up from 10% in 1H 2020). The increase in margin was driven by lower expenses. Is New 90 Day High Low • Nov 06
New 90-day low: AU$0.28 The company is down 2.0% from its price of AU$0.28 on 07 August 2020. The Australian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 33% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.21 per share. Is New 90 Day High Low • Sep 29
New 90-day high: AU$0.33 The company is up 29% from its price of AU$0.26 on 01 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 40% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.21 per share. Upcoming Dividend • Sep 24
Upcoming Dividend of AU$0.014 Per Share Will be paid on the 16th of October to those who are registered shareholders by the 1st of October. The trailing yield of 4.5% is below the top quartile of Australian dividend payers (5.6%), but it is higher than industry peers (2.7%). 
